TY - JOUR
T1 - Degree of blood pressure control and incident diabetes mellitus in chinese adults with hypertension
AU - Zhang, Yuanyuan
AU - Nie, Jing
AU - Zhang, Yan
AU - Li, Jianping
AU - Liang, Min
AU - Wang, Guobao
AU - Tian, Jianwei
AU - Liu, Chengzhang
AU - Wang, Binyan
AU - Cui, Yimin
AU - Wang, Xiaobin
AU - Huo, Yong
AU - Xu, Xiping
AU - Hou, Fan Fan
AU - Qin, Xianhui
N1 - Funding Information:
This work was supported by funding from the following: the National Key Research and Development Program (2016YFE0205400, 2018ZX09739010, 2018ZX09301034003), the Science and Technology Planning Project of Guangzhou, China (201707020010), the Science, Technology and Innovation Committee of Shenzhen (JSGG20170412155639040, GJHS20 170314114526143, JSGG20180703155802047), the Economic, Trade and Information Commission of Shenzhen Municipality (20170505161556110, 201705051609263 90), the National Natural Science Foundation of China (81730019, 81973133), and Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University (2017J009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the article.
Funding Information:
Dr Xiping Xu reports grants from the National Key Research and Development Program (2016YFE0205400, 2018ZX09739010, 2018ZX0 9301034003), the Science and Technology Planning Project of Guangzhou, China (201707020010), the Science, Technology and Innovation Committee of Shenzhen (JSGG20170412155639040, GJHS20170314114526143, JSG G20180703155802047), the Economic, Trade and Information Commission of Shenzhen Municipality (20170505161556110, 20170505160926390). Dr Xianhui Qin reports grants from the National Natural Science Foundation of China (81730019, 81973133), Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University (2017J009). The remaining authors have no disclosures to report.
Publisher Copyright:
© 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.
PY - 2020/8/16
Y1 - 2020/8/16
N2 - BACKGROUND: The association between blood pressure (BP) control and incident diabetes mellitus remains unknown. We aim to investigate the association between degree of time-averaged on-treatment systolic blood pressure (SBP) control and incident diabetes mellitus in hypertensive adults. METHODS AND RESULTS: A total of 14 978 adults with hypertension without diabetes mellitus at baseline were included from the CSPPT (China Stroke Primary Prevention Trial). Participants were randomized double-masked to daily enalapril 10 mg and folic acid 0.8 mg or enalapril 10 mg alone. BP measurements were taken every 3 months after randomization. The primary outcome was incident diabetes mellitus, defined as physician-diagnosed diabetes mellitus, or use of glucose-lowering drugs during follow-up, or fasting glucose ≥126 mg/dL at the exit visit. Over a median of 4.5 years, a significantly higher risk of incident diabetes mellitus was found in participants with time-averaged on-treatment SBP 130 to <140 mm Hg (10.3% versus 7.4%; odds ratio [OR], 1.37; 95% CI, 1.15‒1.64), compared with those with SBP 120 to <130 mm Hg. Moreover, the risk of incident diabetes mellitus increased by 24% (OR, 1.24; 95% CI, 1.00‒1.53) and the incidence of regression to normal fasting glucose (<100 mg/dL) decreased by 29% (OR, 0.71; 95% CI, 0.57‒0.89) in participants with intermediate BP control (SBP/dias-tolic blood pressure, 130 to <140 and/or 80 to <90 mm Hg), compared with those with a tight BP control of <130/<80 mm Hg. Similar results were found when the time-averaged BP were calculated using the BP measurements during the first 6-or 24-month treatment period, or in the analysis using propensity scores. CONCLUSIONS: In this non-diabetic, hypertensive population, SBP control in the range of 120 to <130 mm Hg, compared with the 130 to <140 mm Hg, was associated with a lower risk of incident diabetes mellitus.
AB - BACKGROUND: The association between blood pressure (BP) control and incident diabetes mellitus remains unknown. We aim to investigate the association between degree of time-averaged on-treatment systolic blood pressure (SBP) control and incident diabetes mellitus in hypertensive adults. METHODS AND RESULTS: A total of 14 978 adults with hypertension without diabetes mellitus at baseline were included from the CSPPT (China Stroke Primary Prevention Trial). Participants were randomized double-masked to daily enalapril 10 mg and folic acid 0.8 mg or enalapril 10 mg alone. BP measurements were taken every 3 months after randomization. The primary outcome was incident diabetes mellitus, defined as physician-diagnosed diabetes mellitus, or use of glucose-lowering drugs during follow-up, or fasting glucose ≥126 mg/dL at the exit visit. Over a median of 4.5 years, a significantly higher risk of incident diabetes mellitus was found in participants with time-averaged on-treatment SBP 130 to <140 mm Hg (10.3% versus 7.4%; odds ratio [OR], 1.37; 95% CI, 1.15‒1.64), compared with those with SBP 120 to <130 mm Hg. Moreover, the risk of incident diabetes mellitus increased by 24% (OR, 1.24; 95% CI, 1.00‒1.53) and the incidence of regression to normal fasting glucose (<100 mg/dL) decreased by 29% (OR, 0.71; 95% CI, 0.57‒0.89) in participants with intermediate BP control (SBP/dias-tolic blood pressure, 130 to <140 and/or 80 to <90 mm Hg), compared with those with a tight BP control of <130/<80 mm Hg. Similar results were found when the time-averaged BP were calculated using the BP measurements during the first 6-or 24-month treatment period, or in the analysis using propensity scores. CONCLUSIONS: In this non-diabetic, hypertensive population, SBP control in the range of 120 to <130 mm Hg, compared with the 130 to <140 mm Hg, was associated with a lower risk of incident diabetes mellitus.
KW - Degree of blood pressure control
KW - Hypertension
KW - Incident diabetes mellitus
KW - Regression to normal fasting glucose
KW - Systolic blood pressure
UR - http://www.scopus.com/inward/record.url?scp=85089709257&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089709257&partnerID=8YFLogxK
U2 - 10.1161/JAHA.120.017015
DO - 10.1161/JAHA.120.017015
M3 - Article
C2 - 32755254
AN - SCOPUS:85089709257
SN - 2047-9980
VL - 9
JO - Journal of the American Heart Association
JF - Journal of the American Heart Association
IS - 16
M1 - e017015
ER -